Different signaling mechanisms regulating IL-6 expression by LPS between gingival fibroblasts and mononuclear cells: Seeking the common target

Clinical Immunology

Volumn 143, Issue 2, 2012, Pages 188-199

  Jin, Junfei ^b   Sundararaj, Kamala P ^b   Samuvel, Devadoss J ^b   Zhang, Xiaoming ^b   Li, Yanchun ^b   Lu, Zhongyang ^b   Lopes Virella, Maria F ^a,b   Huang, Yan ^a,b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cytokine; Gene expression; Inflammation; LPS; Signal transduction; Transcription

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 (4 TERT BUTYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PARTHENOLIDE; PROTEIN C FOS; SIMVASTATIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1;

ARTICLE; CELL ACTIVATION; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG TARGETING; ENZYME ACTIVITY; FIBROBLAST; GINGIVA; GINGIVAL FIBROBLAST; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CELLS, CULTURED; FIBROBLASTS; GINGIVA; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; NF-KAPPA B; PROTEIN KINASE INHIBITORS; RNA, MESSENGER; U937 CELLS;

EID: 84862801107     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.01.019     Document Type: Article

References (38)

1. Iacopino A.M. Periodontitis and diabetes interrelationships: role of inflammation. Ann. Periodontol. 2001, 6:125-137.
2. Nichols T.C., Fischer T.H., Deliargyris E.N., Baldwin A.S. Role of nuclear factor-kappa B (NF-kappa B) in inflammation, periodontitis, and atherogenesis. Ann. Periodontol. 2001, 6:20-29.
3. Ridker P.M., Silvertown J.D. Inflammation, C-reactive protein, and atherothrombosis. J. Periodontol. 2008, 79:1544-1551.
4. Page R.C. The role of inflammatory mediators in the pathogenesis of periodontal disease. J. Periodontal Res. 1991, 26:230-242.
5. Ishihara K., Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 2002, 13:357-368.
6. Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res. Ther. 2006, 8(Suppl. 2):S2.
7. Tanaka T., Narazaki M., Kishimoto T. Therapeutic targeting of the interleukin-6 receptor. Annu. Rev. Pharmacol. Toxicol. 2012, 52:199-219.
8. Li Y., Samuvel D.J., Sundararaj K.P., Lopes-Virella M.F., Huang Y. IL-6 and high glucose synergistically upregulate MMP-1 expression by U937 mononuclear phagocytes via ERK1/2 and JNK pathways and c-Jun. J. Cell. Biochem. 2010, 110:248-259.
9. Patil C., Zhu X., Rossa C., Kim Y.J., Kirkwood K.L. p38 MAPK regulates IL-1beta induced IL-6 expression through mRNA stability in osteoblasts. Immunol. Investig. 2004, 33:213-233.
10. Blanchard F., Duplomb L., Baud'huin M., Brounais B. The dual role of IL-6-type cytokines on bone remodeling and bone tumors. Cytokine Growth Factor Rev. 2009, 20:19-28.
11. Sundararaj K.P., Samuvel D.J., Li Y., Sanders J.J., Lopes-Virella M.F., Huang Y. Interleukin-6 released from fibroblasts is essential for up-regulation of matrix metalloproteinase-1 expression by U937 macrophages in coculture: cross-talking between fibroblasts and U937 macrophages exposed to high glucose. J. Biol. Chem. 2009, 284:13714-13724.
12. Sundstrom C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 1976, 17:565-577.
13. Samuvel D.J., Sundararaj K.P., Li Y., Lopes-Virella M.F., Huang Y. Adipocyte-mononuclear cell interaction, Toll-like receptor 4 activation, and high glucose synergistically up-regulate osteopontin expression via an interleukin 6-mediated mechanism. J. Biol. Chem. 2010, 285:3916-3927.
14. Hu Y., Cheng L., Hochleitner B.W., Xu Q. Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler. Thromb. Vasc. Biol. 1997, 17:2808-2816.
15. Jin Y.J., Park I., Hong I.K., Byun H.J., Choi J., Kim Y.M., Lee H. Fibronectin and vitronectin induce AP-1-mediated matrix metalloproteinase-9 expression through integrin alpha(5)beta(1)/alpha(v)beta(3)-dependent Akt, ERK and JNK signaling pathways in human umbilical vein endothelial cells. Cell. Signal. 2011, 23:125-134.
16. Shin Y.H., Son K.N., Lee G.W., Kwon B.S., Kim J. Transcriptional regulation of human CC chemokine CCL15 gene by NF-kappaB and AP-1 elements in PMA-stimulated U937 monocytoid cells. Biochim. Biophys. Acta 2005, 1732:38-42.
17. Sundararaj K.P., Samuvel D.J., Li Y., Nareika A., Slate E.H., Sanders J.J., Lopes-Virella M.F., Huang Y. Simvastatin suppresses LPS-induced MMP-1 expression in U937 mononuclear cells by inhibiting protein isoprenylation-mediated ERK activation. J. Leukoc. Biol. 2008, 84:1120-1129.
18. He Y.P., Zhao L.Y., Zheng Q.S., Liu S.W., Zhao X.Y., Lu X.L., Niu X.L., Li X. Involvement of ERK and AKT signaling in the growth effect of arginine vasopressin on adult rat cardiac fibroblast and the modulation by simvastatin. Mol. Cell. Biochem. 2008, 317:33-41.
19. Fazal F., Bijli K.M., Minhajuddin M., Rein T., Finkelstein J.N., Rahman A. Essential role of cofilin-1 in regulating thrombin-induced RelA/p65 nuclear translocation and intercellular adhesion molecule 1 (ICAM-1) expression in endothelial cells. J. Biol. Chem. 2009, 284:21047-21056.
20. Zerfaoui M., Errami Y., Naura A.S., Suzuki Y., Kim H., Ju J., Liu T., Hans C.P., Kim J.G., Abd Elmageed Z.Y., Koochekpour S., Catling A., Boulares A.H. Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation. J. Immunol. 2010, 185:1894-1902.
21. Ghashghaeinia M., Toulany M., Saki M., Bobbala D., Fehrenbacher B., Rupec R., Rodemann H.P., Ghoreschi K., Rocken M., Schaller M., Lang F., Wieder T. The NFkB pathway inhibitors Bay 11-7082 and parthenolide induce programmed cell death in anucleated Erythrocytes. Cell. Physiol. Biochem. 2011, 27:45-54.
22. Eugui E.M., DeLustro B., Rouhafza S., Ilnicka M., Lee S.W., Wilhelm R., Allison A.C. Some antioxidants inhibit, in a co-ordinate fashion, the production of tumor necrosis factor-alpha, IL-beta, and IL-6 by human peripheral blood mononuclear cells. Int. Immunol. 1994, 6:409-422.
23. Gutierrez-Venegas G., Kawasaki-Cardenas P., Arroyo-Cruz S.R., Maldonado-Frias S. Luteolin inhibits lipopolysaccharide actions on human gingival fibroblasts. Eur. J. Pharmacol. 2006, 541:95-105.
24. Kobayashi H., Yoshida R., Kanada Y., Fukuda Y., Yagyu T., Inagaki K., Kondo T., Kurita N., Suzuki M., Kanayama N., Terao T. Suppression of lipopolysaccharide-induced cytokine production of gingival fibroblasts by a soybean, Kunitz trypsin inhibitor. J. Periodontal Res. 2005, 40:461-468.
25. Wang P.L., Azuma Y., Shinohara M., Ohura K. Toll-like receptor 4-mediated signal pathway induced by Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Biochem. Biophys. Res. Commun. 2000, 273:1161-1167.
26. Wang P.L., Ohura K. Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts-CD14 and Toll-like receptors. Crit. Rev. Oral Biol. Med. 2002, 13:132-142.
27. Matsushita K., Motani R., Sakuta T., Nagaoka S., Matsuyama T., Abeyama K., Maruyama I., Takada H., Torii M. Lipopolysaccharide enhances the production of vascular endothelial growth factor by human pulp cells in culture. Infect. Immun. 1999, 67:1633-1639.
28. Dhar A., Young M.R., Colburn N.H. The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol. Cell. Biochem. 2002, 234-235:185-193.
29. Lee Z.H., Kim H.H. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem. Biophys. Res. Commun. 2003, 305:211-214.
30. Hamada H., Sawyer R.T., Kittle L.A., Newman L.S. Beryllium-stimulation does not activate transcription factors in a mouse hybrid macrophage cell line. Toxicology 2000, 143:249-261.
31. Medicherla R., Leers-Sucheta S., Luo Y., Azhar S. Impaired activation of AP-1 and altered expression of constituent proteins in rat adrenal during ageing. Mech. Ageing Dev. 2001, 122:1169-1186.
32. Nareika A., Maldonado A., He L., Game B.A., Slate E.H., Sanders J.J., London S.D., Lopes-Virella M.F., Huang Y. High glucose-boosted inflammatory responses to lipopolysaccharide are suppressed by statin. J. Periodontal Res. 2007, 42:31-38.
33. Rusconi F., Parizzi F., Garlaschi L., Assael B.M., Sironi M., Ghezzi P., Mantovani A. Interleukin 6 activity in infants and children with bacterial meningitis. The Collaborative Study on Meningitis. Pediatr. Infect. Dis. J. 1991, 10:117-121.
34. Geivelis M., Turner D.W., Pederson E.D., Lamberts B.L. Measurements of interleukin-6 in gingival crevicular fluid from adults with destructive periodontal disease. J. Periodontol. 1993, 64:980-983.
35. Rattazzi M., Puato M., Faggin E., Bertipaglia B., Zambon A., Pauletto P. C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders?. J. Hypertens. 2003, 21:1787-1803.
36. Kristiansen O.P., Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent?. Diabetes 2005, 54(Suppl. 2):S114-S124.
37. Moutsopoulos N.M., Madianos P.N. Low-grade inflammation in chronic infectious diseases: paradigm of periodontal infections. Ann. N. Y. Acad. Sci. 2006, 1088:251-264.
38. Lowe G.D. The relationship between infection, inflammation, and cardiovascular disease: an overview. Ann. Periodontol. 2001, 6:1-8.